Clinical Practice Guidelines
Coordinating Committee Representatives' Financial Disclosures
The disclosure and management of real or perceived potential financial conflicts of interest are a critical step in building public trust in clinical guidelines. To that end, the NIAID has established a procedure that insures maximum transparency of the guidelines development process by reporting the affiliations and activities of members of the Coordinating Committee.
- Dr. Bahna has received funding/grant support from Genentech.
- Dr. Bergman has no relevant financial interests.
- Ms. Book has no relevant financial interests.
- Dr. Bradsher has no relevant financial interests.
- Dr. Brasler has no relevant financial interests.
- Dr. Czinn has no relevant financial interests.
- Dr. Decker has no relevant financial interests.
- Dr. Eichenfield has received funding/grant support from a variety of not-for-profit foundations, as well as Astellas, Ferndale, Johnson & Johnson, Novartis, Sinclair, Stiefel, and Therapeutics Inc.
- Dr. Fuchs is an executive board member for the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition.
- Ms. Heller has no relevant financial interests.
- Dr. Huss has no relevant financial interests.
- Dr. Kline holds, or is listed as an inventor on U.S. patents #6,207,646, #6,239,116, and #20,030,050,261 on “Immunostimulatory nucleic acid molecules.” He has served on the speaker bureaus for GlaxoSmithKline, Novartis, Genentech, and Astra-Zeneca. Dr. Kline has received funding/grant support from Genentech/Novartis, GlaxoSmithKline and Schering-Plough.
- Ms. Mays has no relevant financial interests.
- Ms. McCall has no relevant financial interests.
- Dr. Muraro has no relevant financial interests.
- Mr. Pacenza has no relevant financial interests.
- Dr. Papadopoulos has no relevant financial interests.
- Dr. Sampson holds, or is listed as an inventor on, multiple U.S. Patents related to Food Allergy. He owns stock in Allertein Therapeutics. He is the Immediate Past President of the American Academy of Allergy, Asthma and Immunology. He has served as a consultant for Allertein Therapeutics, the American Academy of Allergy, Asthma and Immunology, the Food Allergy Initiative, and Schering Plough. He has received funding/grant support for research projects from the Food Allergy Initiative, the NIH (DRR, NIAID, NCCAMS), and Phadia AB. He is a co-owner of Herbal Spring, LLC.
- Dr. Sicherer has served as a medical consultant for the Food Allergy Initiative. He has received funding/grant support for research projects from the Food Allergy and Anaphylaxis Network, the Food Allergy Initiative, the NIH, and the USDA.
- Ms. Smith Edge has no relevant financial interests.
- Ms. Williams has no relevant financial interests.
- Dr. J. Wood has served as a speaker for Sonoran Ultrasound LLC.
back to top